The availability of a more affordable biosimilar is expected to improve access to advanced cancer treatment not just in major ...
The current state of radiotherapeutics is “the isotope wars” according to Jack Hoppin, CEO of Boston’s Ratio Therapeutics.
The current state of radiotherapeutics is “the isotope wars” according to Jack Hoppin, CEO of Boston’s Ratio Therapeutics.
The Delhi HC ruling does not abolish patents or endorse blanket early entry. Instead, it stresses courts may intervene ...
From a valuation standpoint, Pfizer appears attractive relative to the industry and is trading below its 5-year mean. Going ...
Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...
7hon MSN
Health care roundup: Market talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback